Alliance Management: Turning strategic partnerships into measurable value
A new partnership is exciting and disruptive. We start out in the honeymoon period” The science is promising, teams get to know each other as they kick off their activities, and, depending on the size of the deal, there will be “buzz”. In today’s biopharma ecosystem, strategic alliances are often necessary to bring therapeutics to […]
What’s Next for Biotech in 2026? Join LBBAL’s CEO for Insight Over Coffee
Something like this — does it work for you?Is your biotech ready to grow in 2026?LBBAL Alianza invites you to an essential end-of-year talk to close 2025 with strategic insight. 📅 December 19 – 9:00 AM📍 CEEI Zaragoza, Nave 6 Organized by Arahealth – Aragón Health Cluster, this holiday breakfast sets the stage for a key conversation […]
After the agreement is done: how to ensure your biotech alliance works in practice
Closing a deal is a huge achievement. After months of negotiations, due diligence, and legal wrangling, long nights and stress, a signature. A celebration. Press releases go out. Optimism is high. The alliance enters its honeymoon period.
August in Biotechnology: The Quiet Month That Shapes Alliances
A quiet month… that defines the rest of the year In Europe, August is associated with vacations, lighter agendas, and a slower pace.But in biotechnology and pharma, this apparent quiet is deceptive. While some take a breather, strategic dynamics continue in motion: regulatory deadlines don’t stop, conversations with potential partners carry on, and opportunities to […]
Biotech’s Ecosystem Reset: What’s Really Going On?
In Granada this June, I spoke to a familiar dilemma: how to keep momentum in biotech when funding is tight, valuations are down, and uncertainty is everywhere. I started with a simple idea: we are in a full funding cycle reset. Let’s talk about what that means. After years of exuberant funding (2018–2021), biotech venture […]
Strength in Ecosystems: LBBAL Alianza Joins Arahealth
Innovation in biotechnology doesn’t happen in isolation. It emerges from the interaction of ideas, disciplines, and above all—people. That’s why, for LBBAL Alianza, joining Arahealth is a natural extension of our commitment to building the kind of strategic partnerships that shape the future of health in Aragón and Spain. Arahealth is a space for connection, momentum, […]
A global lens on biotech—a timely conversation
In today’s biotech landscape, what’s strategic is not only scientific. It is also tied to macroeconomic and geopolitical trends. And that’s exactly what we’ll explore on Wednesday, June 11, at the event “Global Strategies for Biotechnology”, held at the Fundación Parque Tecnológico de la Salud in Granada. Over the course of one morning, in four focused sessions […]
Transatlantic Partnering in Biotech and Pharma in 2025: Navigating Choppy Waters
Our industry is undergoing a stress test. There are a multitude of destabilizing factors at play: As should be expected, biotech and pharma companies on both sides of the Atlantic are reevaluating their strategies. There has been a wave of announcements of large, long term investments in the US: Roche with $50 billion over ten […]
Collaboration Across the Atlantic: Why Strategic Alliances Matter More Than Ever in 2025
Imagine two scientists: one in Boston, another in Barcelona. Both driven by purpose, working on a molecule that could change lives. Yet between them lies not only the Atlantic Ocean, but layers of cultural nuance, regulatory divergence, and increasingly, political tension. In my presentation to the Futuro Perfecto community last year, I posed a simple […]
Integrations and tech transfer in biotech and pharma
In the world of biotechnology and the pharmaceutical industry, closing a deal is just the beginning of a much more complex process: operational integration, R&D collaboration, and technology transfer. During key events such as the J.P. Morgan Healthcare Conference (JPM), numerous mergers, acquisitions, and strategic partnerships are announced, but their real success is measured in their execution. Knowing how to integrate and transfer your technology is crucial.